Among the tankyrase inhibitors reported, G007-LK and AZ1366 were shown to effectively suppress CRC growth in vivo, utilizing CRC cell lines and patient-derived tumor xenograft, respectively [12, 13]. This evidence concerns the gene TNKS and colorectal carcinoma.